Skip to main content

stock

TBPH · Theravance Biopharma, Inc.

What Theravance Biopharma, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live TBPH price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on TBPH.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
51,918,754 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
-4.0%
Net
51.6%

Returns

ROE
18.6%
ROA
11.5%

Health

Current ratio
13.5x
Debt/equity
—

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$20.73M—Gross profit: unreported by this company.-$8.28M-$5.90M
10-Q filed 2026-08-11
2026-03-31$17.70M—Gross profit: unreported by this company.-$9.48M-$4.93M
10-Q filed 2026-05-07
2025-12-31$45.89M—Gross profit: unreported by this company.$20.01M$61.02M
10-K filed 2026-03-23
2025-09-30$19.99M—Gross profit: unreported by this company.-$6.46M$3.62M
10-K filed 2026-03-23
2025-06-30$26.20M—Gross profit: unreported by this company.-$2.73M$54.84M
10-Q filed 2026-08-11
2025-03-31$15.39M—Gross profit: unreported by this company.-$14.43M-$13.58M
10-Q filed 2026-05-07
2024-12-31$18.75M—Gross profit: unreported by this company.-$9.20M-$15.53M
10-K filed 2026-03-23
2024-09-30$16.87M—Gross profit: unreported by this company.-$10.84M-$12.70M
10-K filed 2026-03-23
Assets
$469.77M
Equity
$289.70M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$107.46M-$3.60M$105.89M—
2024-12-31$64.38M-$46.95M-$56.42M—
2023-12-31$57.42M-$56.03M-$55.19M—
2022-12-31$51.35M-$91.96M$872.13M—
2021-12-31$55.31M-$257.78M-$199.43M—
2020-12-31$71.86M-$297.63M-$278.02M—
2019-12-31$73.41M-$251.91M-$236.46M—
2018-12-31$60.37M-$238.75M-$215.52M—
2017-12-31$15.39M-$260.12M-$285.40M—
2016-12-31$48.65M-$180.47M-$190.67M-$101.12M

Company filings

events

  • Material agreement, Acquisition or sale completed, Listing standard notice, Shareholder rights changed, Change in control, Executive or director change, Bylaws or fiscal year change, Other event

    Material agreementAcquisition or sale completedListing standard noticeShareholder rights changedChange in controlExecutive or director changeBylaws or fiscal year changeOther event
    Sep 238-K
  • Shareholder vote results

    Shareholder vote results
    Sep 188-K
  • Other event

    Other event
    Sep 108-K
  • Other event

    Other event
    Aug 258-K
  • Results

    Results
    Aug 108-K
  • Material agreement, Regulation FD disclosure, Other event

    Material agreementRegulation FD disclosureOther event
    Jun 298-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Farnum Rhonda

    SVP, COMM & MEDICAL AFFAIRS

    Sale$226,793

    Sep 17, 5:52 PM ET

  • Samaha Eli

    10% owner

    Sale$119,397

    Jul 8, 4:13 PM ET

All insider trades for TBPH

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named TBPH, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about TBPH.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about TBPH.

nakagai

Signals on TBPH come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the TBPH board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Theravance Biopharma, Inc. (TBPH): SEC filings, financials and insider trades · Nakagai